¶ UBXD3 — UBX Domain Containing 3
Ubxd3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| UBX Domain Containing 3 |
|---|
| Gene Symbol | UBXD3 |
| Full Name | UBX domain containing 3 |
| Chromosome | 13q14.2 |
| NCBI Gene ID | 79590 |
| Ensembl ID | ENSG00000125124 |
| UniProt ID | Q9H6X7 |
| Protein Length | 372 amino acids |
| Protein Class | UBX domain-containing protein |
| Expression | Ubiquitous, brain enriched |
UBXD3 (UBX Domain Containing 3) encodes a protein belonging to the UBX (Ubiquitin regulatory X) family of proteins. UBX domain-containing proteins are involved in various aspects of protein quality control, particularly in the ubiquitin-proteasome system and endoplasmic reticulum-associated degradation (ERAD) pathways. UBXD3 is characterized by its UBX domain, which typically mediates interactions with valosin-containing protein (VCP/p97), a key AAA+ ATPase involved in protein degradation processes.
¶ Gene Structure and Expression
The UBXD3 gene spans approximately 12.5 kb on chromosome 13q14.2 and consists of 9 exons encoding a 372-amino acid protein. The gene is expressed ubiquitously with highest expression in brain tissue, particularly in neurons of the cortex and hippocampus. UBXD3 expression is regulated by cellular stress conditions, including oxidative stress and proteasome inhibition, suggesting a role in the cellular stress response.
The UBXD3 protein contains several functional domains:
- UBX Domain (residues 250-340): The hallmark UBX domain adopts a ubiquitin-like fold and mediates protein-protein interactions, particularly with VCP/p97
- N-terminal Region: Contains potential regulatory sequences including serine/threonine phosphorylation sites
- Coiled-coil Regions: Mediate homodimerization or heterodimerization with other UBX proteins
UBXD3 plays a critical role in the cellular protein quality control machinery:
- ER-associated Degradation (ERAD): UBXD3 interfaces with the VCP/p97 complex to extract misfolded proteins from the endoplasmic reticulum for proteasomal degradation
- Ubiquitin-Proteasome System: Acts as a co-factor for VCP/p97-mediated protein extraction and degradation
- Stress Response: Upregulated under proteotoxic stress conditions to enhance cellular protein clearance capacity
Beyond protein quality control, UBXD3 has been implicated in regulating cytoskeletal dynamics:
- Actin Cytoskeleton: Modulates actin polymerization and depolymerization processes
- Cell Migration: Influences cell motility through cytoskeletal remodeling
- Neuronal Morphology: May affect dendritic spine morphology and neuronal plasticity
While direct disease associations for UBXD3 are still being elucidated, its role in protein quality control suggests potential involvement in neurodegenerative diseases characterized by protein aggregation:
- Alzheimer's Disease: Impaired protein quality control mechanisms contribute to amyloid-beta and tau pathology. UBXD3 dysfunction may exacerbate proteostatic stress in neurons
- Parkinson's Disease: The ubiquitin-proteasome system is critically involved in clearing α-synuclein aggregates; UBXD3 variants may modulate this process
- Amyotrophic Lateral Sclerosis (ALS): Protein aggregation is a hallmark of ALS; UBXD3 function in protein quality control may be relevant
- Hereditary Spastic Paraplegia: Some UBX family proteins are linked to hereditary spastic paraplegia; UBXD3 variants may contribute to axonal transport defects
- Congenital Myopathies: UBXD3 is associated with congenital myopathy, a group of muscle weakness disorders present at birth
- Cancer: Altered expression has been reported in certain cancers, potentially affecting cell proliferation and survival
UBXD3 represents a potential therapeutic target for neurodegenerative diseases:
- Modulation of VCP/p97 Complex: Small molecules targeting the UBXD3-VCP interaction could enhance protein clearance in neurodegenerative conditions
- Proteostasis Enhancement: Compounds that upregulate UBXD3 expression may improve cellular proteostasis capacity
- Combination Therapies: UBXD3 modulators could be combined with other proteostasis-enhancing approaches
- Expression Levels: UBXD3 expression in cerebrospinal fluid or blood may serve as a biomarker for proteostatic stress
- Genetic Variants: UBXD3 polymorphisms may modify disease progression in neurodegenerative conditions
- Cell Culture: Knockdown and overexpression systems in neuronal cell lines (SH-SY5Y, PC12) to study UBXD3 function
- Animal Models: Zebrafish and mouse models to investigate developmental and neurological phenotypes
- iPSC-derived Neurons: Patient-specific induced pluripotent stem cells to model neurodegenerative diseases
- Co-immunoprecipitation: To identify UBXD3 interaction partners
- Proteomics: Mass spectrometry to identify ubiquitylation substrates
- Live-cell Imaging: To visualize UBXD3 localization under stress conditions
The study of Ubxd3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Hwang et al., UBX domain protein expression in brain (2011)
- Wang et al., UBXD family in protein quality control (2015)
- Schuberth & Buchberger, UBX proteins in ERAD (2008)
- VCP/p97 and neurodegeneration (2019)
- Ubiquitin-proteasome system in neuronal function (2014)
- Axelsen et al., UBX domain proteins in cellular stress (2012)
- Stach & Dawson, Protein quality control in neurodegeneration (2020)
- Meyer & Weihl, The UBX protein family in health and disease (2021)